Solta Medical’s newest radiofrequency-based device, the Thermage FLX System, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to noninvasively smooth skin on the face, eyes and body. The system uses patented radiofrequency technology to create a uniform heating effect in the deep collagen-rich layers of the skin. This gentle heating tightens existing collagen and stimulates the production of new collagen with little-to-no downtime for the patient. The Thermage FLX features a new optimized energy delivery algorithm, known as AccuREP technology, that automatically measures and tunes the amount of energy delivered to the patient and treatment area. The system also features a vibrating handpiece to help reduce pain during treatment and a new, larger treatment tip that reduces treatment time by 25 percent.
“As pioneers in the aesthetic market, Solta Medical has continued to evolve the Thermage technology to improve upon the efficacy, comfort and results physicians and their patients have come to expect from the brand,: said James Hartman, vice president and general manager, Solta Medical. “The FDA 510(k) clearance of Thermage FLX marks a momentous occasion during the brand’s 15 year anniversary and demonstrates our commitment to our customers as we continue to develop innovative ways to improve on our existing technologies.”